MYC expression	Diffuse Large B Cell Lymphoma	MYC expression	Diffuse Large B Cell Lymphoma	RG6146 Sensitive: C2 – Inclusion Criteria RG6146 Sensitive : C2	RG6146 Sensitive: C2 – Inclusion Criteria RG6146 Sensitive : C2
MYC expression	Diffuse Large B Cell Lymphoma	MYC expression	Diffuse Large B Cell Lymphoma	lenalidomide Sensitive: C2 – Inclusion Criteria lenalidomide Sensitive : C2	lenalidomide Sensitive: C2 – Inclusion Criteria lenalidomide Sensitive : C2
MYC expression	Triple Negative Breast Cancer	MYC expression	Triple Negative Breast Cancer	pembrolizumab + MK-7965 Sensitive: C3 – Early Trials pembrolizumab + MK-7965 Sensitive : C3	pembrolizumab + MK-7965 Sensitive: C3 – Early Trials pembrolizumab + MK-7965 Sensitive : C3
MYC expression	Medulloblastoma	MYC expression	Medulloblastoma	JHU395 Sensitive: D – Preclinical JHU395 Sensitive : D	JHU395 Sensitive: D – Preclinical JHU395 Sensitive : D
MYC expression	Multiple Myeloma	MYC expression	Multiple Myeloma	JQ-1 Sensitive: D – Preclinical JQ-1 Sensitive : D	JQ-1 Sensitive: D – Preclinical JQ-1 Sensitive : D
MYC expression	Multiple Myeloma	MYC expression	Multiple Myeloma	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D	lenalidomide + CCS1477 Sensitive: D – Preclinical lenalidomide + CCS1477 Sensitive : D
MYC expression	Acute Myelogenous Leukemia	MYC expression	Acute Myelogenous Leukemia	CCS1477 Sensitive: D – Preclinical CCS1477 Sensitive : D	CCS1477 Sensitive: D – Preclinical CCS1477 Sensitive : D
MYC expression	Small Cell Lung Cancer	MYC expression	Small Cell Lung Cancer	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D	AZD2811 Sensitive: D – Preclinical AZD2811 Sensitive : D
MYC expression	Ovarian Cancer	MYC expression	Ovarian Cancer	KB-0742 Sensitive: D – Preclinical KB-0742 Sensitive : D	KB-0742 Sensitive: D – Preclinical KB-0742 Sensitive : D

MYC expression

Associations